It is at the top of this page as a stickied post. I don't have cancer indications broken out by type but cancers showing an elevation of CCR5 levels would be amenable to leronlimab treatment. Most likely is that the greater the elevation the greater the response. Prostate cancer shows a high level of CCR5.

https://investorshangout.com/post/view?id=5967123